Skip to content
A2354Assembly2021-2022 SessionSame asS911

Protect Naloxone Carriers

Official title

“Relates to the possession of opioid antagonists”

Sponsor Jeffrey DinowitzAD-81+3 co-sponsorsAffects Legal
Status
Signed by Governor
Impact
4/10
Low
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill prohibits using possession of opioid antagonists like naloxone as evidence of illegal drug activity in certain legal and criminal cases.

Why it matters

  1. Reduces risk for people carrying life-saving medication. By ensuring that possession of opioid antagonists like naloxone cannot be used as evidence of drug offenses or as proof that a property is being used for illegal drug activity, the bill removes a significant deterrent for individuals who might otherwise be afraid to carry or administer these medications during an opioid overdose emergency.

  2. Supports public health and harm reduction efforts. The legislation aligns law enforcement and court practices with harm reduction strategies, encouraging broader access to and use of opioid reversal medications without fear of criminal or civil repercussions.

  3. Requires police training and procedural updates. Law enforcement agencies and officers will receive updated training and must adopt new procedures to comply with the law, helping to ensure consistent application and awareness across the criminal justice system.

  4. Applies retroactively to pending cases. The protections and evidentiary restrictions will apply not only moving forward but also to cases that are still pending when the law goes into effect, potentially affecting ongoing prosecutions or property-related proceedings.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Protect Naloxone Carriers

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jeffrey Dinowitz

Assembly Member · Assembly District 81

Chair, Codes

History

  1. Signed chap.431
  2. Delivered to governor
  3. Returned to assembly
  4. Passed senateVote 49–14
  5. 3rd reading cal.386
  6. Substituted for S911
  7. Referred to codes
  8. Delivered to senate
  9. Passed assembly
  10. Advanced to third reading cal.57
  11. Reported
  12. Referred to codes

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S911Senate

Protect Opioid Antagonist Possession

Senate Floor Calendar · Sponsor James Sanders Jr.

Impact 4 · Low0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

2354

2021-2022 Regular Sessions

IN ASSEMBLY

January 14, 2021

Introduced by M. of A. DINOWITZ -- read once and referred to the Committee on Codes

AN ACT to amend the criminal procedure law, the civil practice law and rules and the executive law, in relation to the possession of opioid antagonists

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The criminal procedure law is amended by adding a new section 60.49 to read as follows: § 60.49 Possession of opioid antagonists; receipt into evidence.

1. Evidence that a person was in possession of an opioid antagonist may not be admitted at any trial, hearing or other proceeding in a prosecution for any offense under sections 220.03, 220.06, 220.09, 220.16, 220.18, or 220.21 of the penal law for the purpose of establishing probable cause for an arrest or proving any person's commission of such offense.

2. For the purposes of this section, opioid antagonist is defined as a drug approved by the Food and Drug Administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the body and shall be limited to naloxone and other medications approved by the department of health for such purpose.

§ 2. The civil practice law and rules is amended by adding a new section 4519-a to read as follows:

§ 4519-a. Possession of opioid antagonists; receipt into evidence. 1. Possession of an opioid antagonist may not be received in evidence in any trial, hearing or proceeding pursuant to subdivision one of section two hundred thirty-one and paragraph three of subdivision b of section two hundred thirty-three of the real property law or subdivision five of section seven hundred eleven and subdivision one of section seven hundred fifteen of the real property actions and proceedings law as

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD05191-01-1

A. 2354 2

evidence that the building or premises are being used for illegal trade, manufacture, or other illegal business.

2. For the purposes of this section, opioid antagonist shall have the same meaning as set forth in subdivision two of section 60.49 of the criminal procedure law.

§ 3. The executive law is amended by adding a new section 214-g to read as follows:

§ 214-g. Opioid antagonist awareness. The superintendent, in cooperation with the department of health and the office of alcoholism and substance abuse services, shall, for all members of the division of state police: (1) develop, maintain and disseminate appropriate instruction regarding section 60.49 of the criminal procedure law, and (2) establish and implement written procedures and policies in the event a member of the division of state police encounters a person who possesses opioid antagonists.

§ 4. Section 841 of the executive law is amended by adding a new subdivision 7-b to read as follows:

7-b. Take such steps as may be necessary to ensure that all police officers and peace officers certified pursuant to subdivision three of this section receive appropriate instruction regarding section 60.49 of the criminal procedure law relating to the introduction of opioid antagonists into evidence in certain cases.

§ 5. This act shall take effect on the sixtieth day after it shall have become a law and shall apply to all cases pending on and after such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.